In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Merck & SmithKline Beecham co-promote Zocor

Executive Summary

Merck and SmithKline Beecham will co-promote Zocor, a newly-approved Merck drug which lowers cholesterol, in the US. In return, Merck will have future co-promotion rights to an unnamed SmithKline Beecham product (rumored to be Seroxat.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Co-Promotion
    • Marketing (Licensing)
    • Product or Technology Swap

Related Companies

UsernamePublicRestriction

Register